Owner Progenics Pharmaceuticals, Inc. Cornell Research Foundation, Inc.

Inventors Olson, William C; Moore, John P; Sanders, Rogier; Schulke, Norbert; Lu, Min; Binley, James M; Maddon, Paul J; Gardner, Jason

Agent Davies Collison Cave

Pub. Number AU-B-2002335709

PCT Number PCT/US02/28331

PCT Pub. Number WO2003/022869

Priority 60/317,764 06.09.01 US; 60/370,264 05.04.02 US; 60/317,775 06.09.01 US; 60/317,909 06.09.01 US; 60/370,410 05.04.02 US; 60/317,910 06.09.01 US

Filing date 6 September 2002

Wipo publication date 24 March 2003

Acceptance publication date 27 November 2008

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/48 (2006.01) Mutation or genetic engineering

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione